가상 임상시험 시장 : 연구 설계, 관련별 - 세계 예측(2025-2030년)

The Virtual Clinical Trials Market was valued at USD 3.81 billion in 2023, expected to reach USD 4.66 billion in 2024, and is projected to grow at a CAGR of 22.44%, to USD 15.72 billion by 2030.

Virtual clinical trials (VCTs) are innovative approaches in clinical research where the traditional aspects of trial conduction are complemented or replaced by digital tools and platforms, enabling remote participation and data collection. The necessity for VCTs arises from the need to enhance participant diversity, reduce costs, and improve patient accessibility and compliance, especially pertinent during global events like pandemics where physical distancing is vital. They find application in numerous phases of drug and therapy development, particularly where patient-centric data collection is paramount. Key end-users include pharmaceutical companies, biotechnology firms, and contract research organizations aiming to streamline operations and reach broader demographics.

Market insights reveal a surge in digital health innovations and an increasing acceptance of telemedicine, significantly influencing growth. Factors such as advancements in wearable technology, AI, and machine learning are driving efficiencies and personalization in VCTs, opening up opportunities for further integration of real-world evidence in research. Companies are capitalizing on these advancements by investing in sophisticated data management solutions and ensuring compliance with evolving regulatory standards. However, limitations include data privacy concerns, technological biases, and varying international regulations that could hinder widespread adoption. The lack of infrastructure in certain regions and the digital divide between different demographic groups pose significant challenges.

For business growth, areas of innovation include development of secure platforms for decentralized trials, enhancement of digital patient recruitment strategies, and leveraging blockchain for data security. Research into AI's role in predictive analytics and patient monitoring is also promising. Market dynamics are characterized by rapid technological advancements, which necessitate agile strategies and partnerships for effective market penetration. Companies should focus on forging collaborations with tech firms to drive product innovation, and engage with regulatory bodies to shape favorable landscapes for VCTs. Overall, tapping into patient-centric innovations while addressing privacy and regulatory challenges will be crucial for the sustained growth and success of virtual clinical trials.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virtual Clinical Trials Market

The Virtual Clinical Trials Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing adoption of telehealth
  • Growing adoption of digitization in healthcare sector globally
  • Proliferation in research and development activities coupled with favorable government support
• Market Restraints
  • Concerns over large data collection, data accuracy and reliability, and technological failure
• Market Opportunities
  • Integration of new technologies in clinical trials
  • Emerging collaborations between software, biotechnology and clinical research companies
• Market Challenges
  • Cumbersome and difficult process with enrolment and engagement activities

Porter's Five Forces: A Strategic Tool for Navigating the Virtual Clinical Trials Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virtual Clinical Trials Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virtual Clinical Trials Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virtual Clinical Trials Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virtual Clinical Trials Market

A detailed market share analysis in the Virtual Clinical Trials Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virtual Clinical Trials Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virtual Clinical Trials Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virtual Clinical Trials Market

A strategic analysis of the Virtual Clinical Trials Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virtual Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Clinical Ink, Inc. by GI Partners, CliniOps, Inc, Everest Global, Inc, ICON PLC, IQVIA Inc., Medable, Inc., Medidata Solutions by Dassault Systemes S.E., Medpace, Inc., MedPoint Digital, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Pfizer Inc., and VirTrial, LLC by Signant Health.

Market Segmentation & Coverage

This research report categorizes the Virtual Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Study Design, market is studied across Expanded Access Trials, Interventional Trials, and Observational Trials.
• Based on Implication, market is studied across Cardiovascular Disease and Oncology.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing adoption of telehealth
    • 5.1.1.2. Growing adoption of digitization in healthcare sector globally
    • 5.1.1.3. Proliferation in research and development activities coupled with favorable government support
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns over large data collection, data accuracy and reliability, and technological failure
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of new technologies in clinical trials
    • 5.1.3.2. Emerging collaborations between software, biotechnology and clinical research companies
  • 5.1.4. Challenges
    • 5.1.4.1. Cumbersome and difficult process with enrolment and engagement activities
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Virtual Clinical Trials Market, by Study Design

• 6.1. Introduction
• 6.2. Expanded Access Trials
• 6.3. Interventional Trials
• 6.4. Observational Trials

7. Virtual Clinical Trials Market, by Implication

• 7.1. Introduction
• 7.2. Cardiovascular Disease
• 7.3. Oncology

8. Americas Virtual Clinical Trials Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Virtual Clinical Trials Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Virtual Clinical Trials Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AiCure, LLC
• 2. Clinical Ink, Inc. by GI Partners
• 3. CliniOps, Inc
• 4. Everest Global, Inc
• 5. ICON PLC
• 6. IQVIA Inc.
• 7. Medable, Inc.
• 8. Medidata Solutions by Dassault Systemes S.E.
• 9. Medpace, Inc.
• 10. MedPoint Digital, Inc.
• 11. Navitas Inc.
• 12. Oracle Corporation
• 13. Parexel International Corporation
• 14. Pfizer Inc.
• 15. VirTrial, LLC by Signant Health